Star Lab, INC
Star Lab, INC was paid $5.15M by Medicaid between Jan 2018 and Dec 2024, across 60 billing codes. Its largest line is U0004, 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r — 59% of everything it billed.
33Billing provider infoSTAR LAB, INC
FRANKLIN PARK, IL 60131
FRANKLIN PARK, IL 60131
33aNPI1720378524assigned 04/13/2011
33bProvider typeMedical Technologist
28Total paid$5.15M
24GClaims279,842
24DCodes billed60
24AFirst – last monthJan 2018 – Dec 2024
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 1,553 | $6K | |
| 2019 | 22,457 | $133K | |
| 2020 | 74,911 | $1.57M | |
| 2021 | 49,268 | $1.23M | |
| 2022 | 63,222 | $1.42M | |
| 2023 | 43,244 | $617K | |
| 2024incomplete | 25,187 | $173K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| U0004 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r | 59% | 46,864 | 16,848 | $3.02M |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 8.8% | 21,668 | 8,063 | $454K |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 7.7% | 21,184 | 8,674 | $397K |
| P9603 | Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated miles actually travelled | 4.7% | 14,545 | 7,841 | $240K |
| 84443 | Thyroid stimulating hormone (TSH) | 2.5% | 9,274 | 6,883 | $130K |
| 80053 | Comprehensive metabolic panel | 2.5% | 16,490 | 10,209 | $129K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 2.2% | 22,526 | 13,352 | $115K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 1.4% | 7,143 | 5,411 | $74K |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | 1.1% | 1,310 | 633 | $56K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 9,144 | 6,927 | $50K |
| 85610 | <1% | 13,738 | 5,168 | $46K | |
| 80061 | Lipid panel | <1% | 9,469 | 6,986 | $41K |
48 more codes
| 82533 | <1% | 3,316 | $36K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 4,141 | $31K |
| 84436 | <1% | 5,190 | $29K | |
| P9604 | Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated trip charge | <1% | 12,027 | $26K |
| 84479 | <1% | 4,234 | $22K | |
| 85651 | <1% | 5,732 | $22K | |
| 82607 | <1% | 1,938 | $21K | |
| 83735 | <1% | 3,473 | $20K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 3,135 | $19K |
| 81001 | <1% | 6,646 | $17K | |
| 87075 | <1% | 1,789 | $16K | |
| 87184 | <1% | 2,237 | $15K | |
| 82043 | <1% | 4,072 | $14K | |
| 82746 | <1% | 1,245 | $13K | |
| 82728 | <1% | 1,296 | $9K | |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | <1% | 37 | $9K |
| 36415 | Collection of venous blood by venipuncture | <1% | 15,507 | $9K |
| 83540 | <1% | 1,451 | $8K | |
| 82985 | <1% | 644 | $8K | |
| 84153 | <1% | 712 | $7K | |
| 84439 | <1% | 848 | $7K | |
| 80164 | <1% | 788 | $6K | |
| 82570 | <1% | 1,408 | $6K | |
| G2024 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]) from an individual in a snf or by a laboratory on behalf of a hha, any specimen source | <1% | 392 | $6K |
| 83880 | <1% | 273 | $5K | |
| 86140 | <1% | 1,108 | $4K | |
| 86141 | <1% | 264 | $4K | |
| 85730 | <1% | 448 | $2K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 47 | $2K |
| 86706 | <1% | 167 | $2K | |
| 86803 | <1% | 128 | $2K | |
| 84550 | <1% | 490 | $2K | |
| 83550 | <1% | 192 | $1K | |
| 86704 | <1% | 103 | $1K | |
| 87340 | <1% | 92 | $991.80 | |
| 84480 | <1% | 98 | $902.25 | |
| 86328 | <1% | 48 | $892.40 | |
| 86708 | <1% | 121 | $885.70 | |
| 86703 | <1% | 43 | $764.26 | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 20 | $745.60 |
| 84100 | <1% | 275 | $707.59 | |
| 84155 | <1% | 149 | $272.67 | |
| 80076 | <1% | 77 | $256.81 | |
| 86705 | <1% | 20 | $250.18 | |
| 86694 | <1% | 19 | $210.87 | |
| 84154 | <1% | 14 | $185.31 | |
| 86709 | <1% | 21 | $90.91 | |
| 83721 | 0% | 12 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialFELICELDA, RICHARD (ADMINISTRATOR)